Only 10 percent of PSORS1 carriers affectedPhysician: James T. Elder, M.D., Ph.D.
Nearly half of FDA-authorized AI tools may be ineffective
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Study Compares Dose Escalation with Biologics in Psoriasis
Isotretinoin’s Role in Rosacea Management